Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia.

Clin Microbiol Infect

Institut Pasteur de Nouvelle Calédonie, Nouméa, New Caledonia.

Published: October 2008

Carbapenem-resistant Acinetobacter baumannii (CR-Ab) ranked third, with a frequency of 24.8%, among 202 strains of multidrug-resistant bacteria isolated from clinical samples in the main hospital of New Caledonia in 2004. All CR-Ab isolates were analysed by isoelectric focusing, conjugation, pulsed-field gel electrophoresis and PCR for the presence of carbapenemase genes. Fifty CR-Ab isolates produced carbapenemase OXA-23. The isolates belonged to a single clone presenting several subtypes, suggesting an endemic situation. This study further illustrates the widespread prevalence of carbapenemase OXA-23-producing CR-Ab isolates in the South Pacific.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1469-0691.2008.02068.xDOI Listing

Publication Analysis

Top Keywords

cr-ab isolates
12
carbapenem-resistant acinetobacter
8
acinetobacter baumannii
8
molecular epidemiology
4
epidemiology carbapenem-resistant
4
baumannii caledonia
4
caledonia carbapenem-resistant
4
cr-ab
4
baumannii cr-ab
4
cr-ab ranked
4

Similar Publications

Therapeutic options for carbapenem-resistant Acinetobacter baumannii (CA-AB) are quite limited. Cefiderocol, a novel siderophore cephalosporin, has shown potent in vitro activity against CR-AB, and new tetracycline analogues such as eravacycline and omadacycline have been available in recent years. However, the synergism of cefiderocol with tetracycline analogues against CR-AB has not been well investigated.

View Article and Find Full Text PDF

Objective: This study investigated the distribution and resistance patterns of pathogens in the intensive care unit of a newly established hospital in Guizhou Province to promote the rational use of antibiotics to reduce multidrug resistance.

Methods: A retrospective analysis was conducted on the distribution of pathogens and changes in drug resistance in the ICU of a newly built hospital in Guizhou Province from March 2019 to December 2023. WHONET 5.

View Article and Find Full Text PDF

Background: () disease in the United States is commonly attributed to outbreaks of 1 or 2 monophyletic carbapenem resistance (CR) lineages that vary by region. However, there is limited knowledge regarding CR epidemiology and population structures in the U.S.

View Article and Find Full Text PDF

Acinetobacter baumannii is a bacteria associated with nosocomial infections and outbreaks, difficult to control due to its antibiotic resistance, ability to survive in adverse conditions, and biofilm formation adhering to biotic and abiotic surfaces. Therefore, this study aimed to evaluate the antibiofilm activity of biogenic silver nanoparticle (Bio-AgNP) and polymyxin B alone and combined in biofilms formed by isolates of carbapenem-resistant A. baumannii (CR-Ab).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to examine antimicrobial resistance and biofilm formation in Acinetobacter from healthcare settings in Pakistan, focusing on beta-lactamase genes.
  • A total of 223 imipenem-resistant Acinetobacter isolates were investigated using various tests, including PCR and sequencing, to identify resistance genes and biofilm production.
  • The findings revealed high prevalence of carbapenem-resistant Acinetobacter, particularly associated with wound infections, and common genes linked to resistance and virulence, indicating a significant public health concern.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!